NumQuants

Model profile

Biotech

Risk-adjusted product pipeline, commercial forecast, R&D, CAPEX, and portfolio valuation.

Decision scope

Questions this model helps you examine

01

How do production, market, pricing, development, and regulatory assumptions shape the plan?

02

What operating capacity, working capital, investment, and financing are required?

03

How do risk, bankability, and downside cases affect funding needs and returns?

Model capabilities

What this model includes

The profile below is generated from the same catalogue and workspace definitions used by the application.

Build the case

Inputs and workspaces

  • AssumptionsPortfolio horizon, tax, working capital, and valuation
  • Product pipelineStage, probability, launch, revenue, cost, R&D, and CAPEX rows
  • Clinical developmentStage transitions, trial spend, and milestone economics
  • Commercial & product detailPatient revenue, licensing, operating costs, and CAPEX components
  • Financing & waterfallDebt, covenants, sources and uses, VC method, and shareholder preferences

Review the result

Outputs and analysis

  • Risk-adjusted NPVUSD
  • Portfolio IRRAnnual
  • Peak revenueUSD
  • Peak EBITDAUSD
  • Terminal valueUSD
  • Ending cashUSD
  • Minimum DSCRDebt periods
  • Post-money equityUSD
  • 1 additional metric in the workspace
  • Portfolio forecast and valuationDetailed schedules
  • Pipeline and risk analyticsDetailed schedules

Designed for review

Who this model is for

Governed evidence

The review trail stays with the result.

Each completed calculation preserves the model version, saved inputs, reporting-currency snapshot, immutable run, and result fingerprint used for its reports.

Ready to explore the case?

Start with the governed base case, then adapt it to your project.

Start free with this model